Variant report

Variant	nsv827911
Chromosome Location	chr17:17598715-17599975
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:26)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:26 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:17597022..17599037-chr17:57970421..57971942,2	MCF-7	breast:
2	chr17:17591306..17603641-chr17:17622226..17637880,43	MCF-7	breast:
3	chr17:17597990..17601613-chr17:17723911..17725744,3	MCF-7	breast:
4	chr17:17596418..17598751-chr17:17739588..17742563,3	K562	blood:
5	chr17:17594932..17600890-chr17:17651321..17655426,6	MCF-7	breast:
6	chr17:17596728..17599207-chr2:239693825..239696213,2	MCF-7	breast:
7	chr17:17596031..17599358-chr17:17737943..17741598,5	MCF-7	breast:
8	chr17:17597823..17600507-chr17:17743270..17745727,2	K562	blood:
9	chr17:17596840..17599239-chr17:17655841..17657576,2	MCF-7	breast:
10	chr17:17596829..17599707-chr17:17608179..17611084,3	K562	blood:
11	chr1:28974279..28975242-chr17:17597910..17598840,2	Hela-S3	cervix:
12	chr17:17597749..17599526-chr17:17663082..17665675,2	MCF-7	breast:
13	chr17:17596829..17599707-chr17:17608593..17611084,2	K562	blood:
14	chr17:17566041..17569411-chr17:17596920..17599764,3	MCF-7	breast:
15	chr17:17594795..17598773-chr17:17639856..17643137,4	MCF-7	breast:
16	chr17:17599477..17603323-chr17:17655564..17658131,3	MCF-7	breast:
17	chr17:17571014..17573975-chr17:17596687..17598856,2	K562	blood:
18	chr17:17594258..17600676-chr17:17738917..17745175,15	MCF-7	breast:
19	chr17:17597833..17600762-chr17:17692593..17694977,2	MCF-7	breast:
20	chr17:17596608..17599012-chr17:17739626..17742563,3	K562	blood:
21	chr17:17596211..17599216-chr17:17709321..17712358,3	MCF-7	breast:
22	chr17:17597308..17599805-chr17:17722220..17725065,2	MCF-7	breast:
23	chr17:17598092..17600072-chr17:17758359..17760671,2	MCF-7	breast:
24	chr17:17593686..17602682-chr17:17684488..17692992,14	MCF-7	breast:
25	chr17:17597397..17599561-chr17:17661548..17663067,2	MCF-7	breast:
26	chr17:17596357..17599284-chr17:17741696..17744327,3	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000270103	chromatin interactions
ENSG00000108557	chromatin interactions
ENSG00000108443	chromatin interactions
ENSG00000072310	chromatin interactions

Extended variants
information (count: 55 )
Associated
traits (count: 161 )

Variant overlapped rSNPs/rCNVs (count:55 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs149956304	chr17:17598715-17598716	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs541482399	chr17:17598719-17598720	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs561391412	chr17:17598784-17598785	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs182376431	chr17:17598796-17598797	Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Enhancers Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
5	rs187765528	chr17:17598831-17598832	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs543565255	chr17:17598836-17598837	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs111254178	chr17:17598845-17598846	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs66725320	chr17:17598846-17598847	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs77232262	chr17:17598847-17598848	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs10692662	chr17:17598858-17598859	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs112746083	chr17:17598877-17598878	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs563964166	chr17:17598941-17598942	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs532884656	chr17:17598963-17598964	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs191182025	chr17:17598967-17598968	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs566293900	chr17:17598977-17598978	Bivalent Enhancer Enhancers Flanking Active TSS Weak transcription Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs182967761	chr17:17599036-17599037	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs528692167	chr17:17599050-17599051	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs374747027	chr17:17599051-17599052	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs145120535	chr17:17599064-17599065	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs140786034	chr17:17599106-17599107	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs188550584	chr17:17599107-17599108	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs144613948	chr17:17599126-17599127	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs570116793	chr17:17599138-17599139	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs192889398	chr17:17599141-17599142	Bivalent Enhancer Weak transcription Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs547398893	chr17:17599218-17599219	Weak transcription Genic enhancers Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs572965928	chr17:17599260-17599261	Weak transcription Genic enhancers Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs146686960	chr17:17599340-17599341	Weak transcription Genic enhancers Enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs535296075	chr17:17599418-17599419	Weak transcription Genic enhancers Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs35258176	chr17:17599424-17599425	Weak transcription Genic enhancers Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs555063064	chr17:17599435-17599436	Weak transcription Genic enhancers Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs73292253	chr17:17599466-17599467	Weak transcription Genic enhancers Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs184577355	chr17:17599474-17599475	Weak transcription Genic enhancers Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs563698965	chr17:17599475-17599476	Weak transcription Genic enhancers Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs577450853	chr17:17599532-17599533	Weak transcription Genic enhancers Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs553391920	chr17:17599536-17599537	Weak transcription Genic enhancers Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs188268478	chr17:17599538-17599539	Weak transcription Genic enhancers Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs191162855	chr17:17599542-17599543	Weak transcription Genic enhancers Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs78382030	chr17:17599570-17599571	Weak transcription Genic enhancers Enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs183666237	chr17:17599612-17599613	Weak transcription Genic enhancers Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs528639430	chr17:17599617-17599618	Weak transcription Genic enhancers Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs34493853	chr17:17599632-17599633	Weak transcription Genic enhancers Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs548382512	chr17:17599634-17599635	Weak transcription Genic enhancers Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs561438006	chr17:17599671-17599672	Weak transcription Genic enhancers Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs75592986	chr17:17599729-17599730	Weak transcription Genic enhancers Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs557501345	chr17:17599753-17599754	Weak transcription Genic enhancers Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs140291370	chr17:17599771-17599772	Weak transcription Genic enhancers Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs114865672	chr17:17599799-17599800	Weak transcription Genic enhancers Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs189261613	chr17:17599802-17599803	Weak transcription Genic enhancers Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs11656769	chr17:17599850-17599851	Weak transcription Genic enhancers Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs537630642	chr17:17599862-17599863	Weak transcription Genic enhancers Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:161)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Colorectal cancer	16774939	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Gastric cancer	18160780	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Ductal carcinoma	22052326	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Autism	22543975	CNVD
Melanoma	22183965	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Autism	19492091	CNVD

Chromatin state (count:276 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:17594200-17599600	Enhancers	Fetal Brain Male	brain
2	chr17:17596200-17599400	Flanking Active TSS	Stomach Smooth Muscle	stomach
3	chr17:17596400-17598800	Flanking Active TSS	HMEC	breast
4	chr17:17596400-17599400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
5	chr17:17596600-17599600	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
6	chr17:17597000-17598800	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
7	chr17:17597200-17599200	Flanking Active TSS	Primary hematopoietic stem cells	blood
8	chr17:17597200-17599400	Flanking Active TSS	Dnd41	blood
9	chr17:17597400-17598800	Active TSS	Pancreatic Islets	Pancreatic Islet
10	chr17:17597400-17607000	Enhancers	Fetal Heart	heart
11	chr17:17597600-17598800	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
12	chr17:17597600-17598800	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
13	chr17:17597600-17598800	Active TSS	Colon Smooth Muscle	Colon
14	chr17:17597600-17598800	Active TSS	Fetal Kidney	kidney
15	chr17:17597600-17598800	Active TSS	Ovary	ovary
16	chr17:17597800-17598800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
17	chr17:17597800-17598800	Active TSS	Aorta	Aorta
18	chr17:17598200-17598800	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
19	chr17:17598200-17598800	Flanking Active TSS	Primary mononuclear cells fromperipheralblood	Blood
20	chr17:17598200-17598800	Flanking Active TSS	NH-A	brain
21	chr17:17598200-17599000	Flanking Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
22	chr17:17598200-17599000	Flanking Active TSS	Primary B cells from cord blood	blood
23	chr17:17598200-17599000	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
24	chr17:17598200-17599000	Flanking Active TSS	Adipose Nuclei	Adipose
25	chr17:17598400-17598800	Bivalent Enhancer	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
26	chr17:17598400-17598800	Flanking Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
27	chr17:17598400-17598800	Flanking Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
28	chr17:17598400-17598800	Flanking Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
29	chr17:17598400-17598800	Flanking Active TSS	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
30	chr17:17598400-17598800	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
31	chr17:17598400-17598800	Flanking Active TSS	Primary B cells from peripheral blood	blood
32	chr17:17598400-17598800	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
33	chr17:17598400-17598800	Flanking Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
34	chr17:17598400-17598800	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
35	chr17:17598400-17598800	Flanking Active TSS	Primary T killer naive cells fromperipheralblood	blood
36	chr17:17598400-17598800	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
37	chr17:17598400-17598800	Flanking Active TSS	Esophagus	oesophagus
38	chr17:17598400-17598800	Flanking Active TSS	Fetal Adrenal Gland	Adrenal Gland
39	chr17:17598400-17598800	Flanking Active TSS	Fetal Brain Female	brain
40	chr17:17598400-17598800	Flanking Active TSS	Fetal Intestine Small	intestine
41	chr17:17598400-17598800	Flanking Active TSS	Fetal Muscle Trunk	muscle
42	chr17:17598400-17598800	Flanking Active TSS	Placenta	Placenta
43	chr17:17598400-17598800	Flanking Active TSS	Fetal Stomach	stomach
44	chr17:17598400-17598800	Flanking Active TSS	Fetal Thymus	thymus
45	chr17:17598400-17598800	Flanking Active TSS	Lung	lung
46	chr17:17598400-17598800	Flanking Active TSS	Pancreas	Pancrea
47	chr17:17598400-17598800	Flanking Active TSS	Placenta Amnion	Placenta Amnion
48	chr17:17598400-17598800	Flanking Active TSS	Spleen	Spleen
49	chr17:17598400-17598800	Flanking Active TSS	HUVEC	blood vessel
50	chr17:17598400-17598800	Flanking Active TSS	NHDF-Ad	bronchial

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links